WO2002100338A3 - Compound and composition for delivering active agents - Google Patents

Compound and composition for delivering active agents Download PDF

Info

Publication number
WO2002100338A3
WO2002100338A3 PCT/US2002/018236 US0218236W WO02100338A3 WO 2002100338 A3 WO2002100338 A3 WO 2002100338A3 US 0218236 W US0218236 W US 0218236W WO 02100338 A3 WO02100338 A3 WO 02100338A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
composition
active agents
delivering active
delivering
Prior art date
Application number
PCT/US2002/018236
Other languages
French (fr)
Other versions
WO2002100338A2 (en
Inventor
Andrea Leone-Bay
Original Assignee
Emisphere Tech Inc
Andrea Leone-Bay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc, Andrea Leone-Bay filed Critical Emisphere Tech Inc
Priority to AU2002316200A priority Critical patent/AU2002316200A1/en
Publication of WO2002100338A2 publication Critical patent/WO2002100338A2/en
Publication of WO2002100338A3 publication Critical patent/WO2002100338A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Abstract

Compounds and compositions for the delivery for Parathyroid hormone are provided. Methods of administration and preparation are provided as well.
PCT/US2002/018236 2001-06-08 2002-06-07 Compound and composition for delivering active agents WO2002100338A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002316200A AU2002316200A1 (en) 2001-06-08 2002-06-07 Compound and composition for delivering active agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29711701P 2001-06-08 2001-06-08
US60/297,117 2001-06-08

Publications (2)

Publication Number Publication Date
WO2002100338A2 WO2002100338A2 (en) 2002-12-19
WO2002100338A3 true WO2002100338A3 (en) 2004-02-12

Family

ID=23144924

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/018236 WO2002100338A2 (en) 2001-06-08 2002-06-07 Compound and composition for delivering active agents

Country Status (2)

Country Link
AU (1) AU2002316200A1 (en)
WO (1) WO2002100338A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US9364502B2 (en) 2006-06-28 2016-06-14 Emisphere Technologies, Inc. Gallium nitrate formulations

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9720025A (en) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Compounds and compositions for delivering active agents
RU2332229C2 (en) 2002-02-20 2008-08-27 Эмисфире Текнолоджис Инк. Method of glp-1 molecules introduction
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
CN1968704B (en) 2004-05-19 2010-12-08 爱密斯菲尔科技公司 Topical cromolyn formulations
WO2006072070A2 (en) 2004-12-29 2006-07-06 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
WO2007011958A2 (en) 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
WO2007133944A2 (en) 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
EP2461803B1 (en) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990166A (en) * 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990166A (en) * 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US9364502B2 (en) 2006-06-28 2016-06-14 Emisphere Technologies, Inc. Gallium nitrate formulations

Also Published As

Publication number Publication date
WO2002100338A2 (en) 2002-12-19
AU2002316200A1 (en) 2002-12-23

Similar Documents

Publication Publication Date Title
WO2000007979A3 (en) Compounds and compositions for delivering active agents
WO2003045306A3 (en) Phenoxy amine compounds and compositions for delivering active agents
WO2001032130A3 (en) Phenyl amine carboxylic acid compounds and compositions for delivering active agents
AU2274201A (en) Compounds and compositions for delivering active agents
HK1054918A1 (en) Compounds and compositions for delivering active agents
MXPA01008611A (en) Compounds and compositions for delivering active agents.
WO2005112633A3 (en) Compounds and compositions for delivering active agents
WO2002070438A3 (en) Compositions for delivering bisphosphonates
MXPA03007857A (en) Compounds and compositions for delivering active agents.
CA2338358A1 (en) Compounds and compositions for delivering active agents
WO2002074247A3 (en) Pharmaceutical formulations for sustained release
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
WO2002015959A3 (en) Compounds and compositions for delivering active agents
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2004104018A3 (en) Compositions for delivering peptide yy and pyy agonists
WO2002100338A3 (en) Compound and composition for delivering active agents
WO2005062874A3 (en) Compounds and compositions for delivering active agents
WO2007022532A3 (en) Cyclopropyl compounds and compositions for delivering active agents
EP1676832A3 (en) Compounds and compositions for delivering active agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP